Skip to main content
SpringerLink
Log in

The UK's MHRA has ruled that products containing 1,3-dimethylamylamine (DMAA) must be removed from the UK market

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. The Medicines and Healthcare Products Regulatory Agency.MHRA to remove popular sports supplement used by international athletes from the market Media Release: 28 Aug 2012. Available from: URL: http://www.mhra.gov.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The UK's MHRA has ruled that products containing 1,3-dimethylamylamine (DMAA) must be removed from the UK market. React. Wkly. 1418, 3 (2012). https://doi.org/10.2165/00128415-201214180-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214180-00006

Keywords

Search

Navigation